Variation_Name | GeneID | GeneSymbol | ClinicalSignificance | dbSNP | RCVaccession | TestedInGTR | PhenotypeIDs | Chromosome | Start | Stop | HGVS_c | HGVS_p | HGVS_g | OtherIDs | Disease_ClinVar | Disease_hgmd | NM_018668.4(VPS33B):c.1594C>T (p.Arg532Ter) | 26276 | VPS33B | Pathogenic | 121434383 | RCV000002285; | N | MedGen:C1859722,OMIM:208085,ORPHA:2697 | 15 | 91543193 | 91543193 | NM_018668.4:c.1594C>T | NP_061138.3:p.Arg532Ter | NC_000015.9:g.91543193G>A | OMIM Allelic Variant:608552.0001 | C1859722 208085 Arthrogryposis renal dysfunction cholestasis syndrome | | |
NM_018668.4(VPS33B):c.1312C>T (p.Arg438Ter) | 26276 | VPS33B | Pathogenic | 121434384 | RCV000002286; | N | MedGen:C1859722,OMIM:208085,ORPHA:2697 | 15 | 91545373 | 91545373 | NM_018668.4:c.1312C>T | NP_061138.3:p.Arg438Ter | NC_000015.9:g.91545373G>A | OMIM Allelic Variant:608552.0002 | C1859722 208085 Arthrogryposis renal dysfunction cholestasis syndrome | | |
NM_018668.4(VPS33B):c.1261_1262delCA (p.Gln421Valfs) | 26276 | VPS33B | Pathogenic | 398122408 | RCV000074447; | N | MedGen:C1859722,OMIM:208085,ORPHA:2697 | 15 | 91546325 | 91546326 | NM_018668.4:c.1261_1262delCA | NP_061138.3:p.Gln421Valfs | NC_000015.9:g.91546325_91546326delTG | OMIM Allelic Variant:608552.0007 | C1859722 208085 Arthrogryposis renal dysfunction cholestasis syndrome | | |
NM_018668.4(VPS33B):c.1225+5G>C | 26276 | VPS33B | Pathogenic | 398122407 | RCV000074446; | N | MedGen:C1859722,OMIM:208085,ORPHA:2697 | 15 | 91548102 | 91548102 | NM_018668.4:c.1225+5G>C | | NC_000015.9:g.91548102C>G | OMIM Allelic Variant:608552.0005 | C1859722 208085 Arthrogryposis renal dysfunction cholestasis syndrome | | |
NM_018668.4(VPS33B):c.1130G>C (p.Arg377Pro) | 26276 | VPS33B | association | 864622006 | RCV000204599; | N | MedGen:C1859722,OMIM:208085,ORPHA:2697 | 15 | 91548325 | 91548325 | NM_018668.4:c.1130G>C | NP_061138.3:p.Arg377Pro | NC_000015.9:g.91548325C>G | - | C1859722 208085 Arthrogryposis renal dysfunction cholestasis syndrome | | |
NM_018668.4(VPS33B):c.700+1G>A | 26276 | VPS33B | Pathogenic | 794726658 | RCV000002288; | N | MedGen:C1859722,OMIM:208085,ORPHA:2697 | 15 | 91550179 | 91550179 | NM_018668.4:c.700+1G>A | | NC_000015.9:g.91550179C>T | OMIM Allelic Variant:608552.0004 | C1859722 208085 Arthrogryposis renal dysfunction cholestasis syndrome | | |
NM_018668.3(VPS33B):c.240-577_290-156del | 26276 | VPS33B | Pathogenic | -1 | RCV000074445; | N | MedGen:C1859722,OMIM:208085,ORPHA:2697 | 15 | 91557257 | 91558240 | NM_018668.3:c.240-577_290-156del | | | OMIM Allelic Variant:608552.0006,dbVar:nssv3761621,dbVar:nsv1067904 | C1859722 208085 Arthrogryposis renal dysfunction cholestasis syndrome | | |
NM_018668.4(VPS33B):c.89T>C (p.Leu30Pro) | 26276 | VPS33B | Pathogenic | 121434385 | RCV000002287; | N | MedGen:C1859722,OMIM:208085,ORPHA:2697 | 15 | 91565391 | 91565391 | NM_018668.4:c.89T>C | NP_061138.3:p.Leu30Pro | NC_000015.9:g.91565391A>G | OMIM Allelic Variant:608552.0003 | C1859722 208085 Arthrogryposis renal dysfunction cholestasis syndrome | | |